Enlivex (ENLV) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Enlivex Therapeutics Ltd. reports its financial status, showing a total asset decrease from $36,831 thousand to $31,902 thousand between December 31, 2023, and June 30, 2024. The balance sheet reveals a drop in current assets and an accumulated deficit increase, reflecting a challenging fiscal period with a net loss of $7,236 thousand for the six months ended June 30, 2024. These unaudited figures highlight Enlivex’s financial movements and potential concerns for investors.
For further insights into ENLV stock, check out TipRanks’ Stock Analysis page.
